Clinical Trials Directory

Trials / Completed

CompletedNCT00954018

Microbial Community Composition and Metabolism in Cystic Fibrosis

Respiratory Microbial Community Composition and Metabolism in Cystic Fibrosis

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
2 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Scientist have begun to realize that many types of bacteria often live together as a complex community, and the investigators wish to apply that idea to the bacteria in the respiratory system of people with Cystic Fibrosis (CF). It is possible that the survival of the many millions of bacteria in the CF lung depends on the production of special chemicals that might be made only by very few types of bacteria. If that is true, medicines that interfere with those chemicals could treat the lung infections that cause trouble for nearly all people with CF. The investigators wish to study the production of several potentially critical chemicals by the respiratory bacteria and to examine the effect of those chemicals on the makeup of the entire community of bacteria. To detect all the bacteria in that community, the investigators will use new methods that use bacterial genetic information and can detect hundreds of different types of bacteria in respiratory samples of individual CF patients.

Conditions

Timeline

Start date
2009-08-01
Primary completion
2017-11-10
Completion
2017-11-10
First posted
2009-08-06
Last updated
2023-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00954018. Inclusion in this directory is not an endorsement.